A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/2011
10/13/2011	US20110250199 Immunotoxins and uses thereof
10/13/2011	US20110250196 Pharmaceutical composition using gonadotropin - releasing hormone (gnrh) combined variants as immunogen
10/13/2011	US20110250194 Treatment with Anti-ErbB2 Antibodies
10/13/2011	US20110250192 Use of microrna signatures for assessing risk levels of neuroblastoma patients
10/13/2011	US20110250188 LCMV-GP-VSV-Pseudotyped Vectors and Tumor-Infiltrating Virus-Producing Cells for the Therapy of Tumors
10/13/2011	US20110250185 Tumor suppression using placental stem cells
10/13/2011	US20110250184 Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents in human
10/13/2011	US20110250180 Ccn3 peptides and analogs thereof for therapeutic use
10/13/2011	US20110250179 Methods for treatment and diagnosis of cancer
10/13/2011	US20110250177 Alpha interferon variants
10/13/2011	US20110250175 Tlr7 ligand and uses thereof
10/13/2011	US20110250173 Methods and compositions for inhibition of Treg cells
10/13/2011	US20110250171 Compositions and Methods for Cancer Immunotherapy
10/13/2011	US20110250170 Immunocytokines for Tumour Therapy with Chemotherapeutic Agents
10/13/2011	US20110250169 Derivatives of growth hormone and related proteins
10/13/2011	US20110250168 Sialoadhesin-related compositions and methods
10/13/2011	US20110250167 Method for purifying proteins
10/13/2011	US20110250166 Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer
10/13/2011	US20110250165 Antibodies against CXCR4 and Methods of Use Thereof
10/13/2011	US20110250163 Mono- and di-peg il-10 production; and uses
10/13/2011	US20110250144 Rgd-containing peptidomimetics and uses thereof
10/13/2011	US20110250143 Process for preparing chlorins and their pharmaceutical uses
10/13/2011	US20110250137 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation
10/13/2011	US20110250134 Sustained release nitric oxide from long lived circulating nanoparticles
10/13/2011	US20110250132 Lipoic acid metabolite: useful for drug carrier, nanoparticle conjugate, imaging and hyperthermia therapy
10/13/2011	US20110250130 Tnf-alpha binding proteins
10/13/2011	US20110250129 Bioluminescence imaging-based screening assay and inhibitors of abcg2
10/13/2011	DE102010014411A1 New iron complexes, useful as carbon monoxide and iron releasing molecules for treating e.g. high blood pressure, cancer, tissue damage by irradiation, post-ischemic injury, atherosclerosis, sepsis, angina and myocardial infarction
10/13/2011	CA2800519A1 Biomarkers for mdm2 inhibitors for use in treating disease
10/13/2011	CA2795938A1 Compositions and methods for providing hematopoietic function
10/13/2011	CA2795765A1 Methods for identifying and using inhibitors of casein kinase 1 epsilon isoform for inhibiting the growth and/or proliferation of myc-driven tumor cells
10/13/2011	CA2795695A1 Microrna-controlled recombinant vaccinia virus and use thereof
10/13/2011	CA2795627A1 Compositions and methods for providing hematopoietic function without hla matching
10/13/2011	CA2795423A1 Cluap1 peptides and vaccines including the same
10/13/2011	CA2795350A1 Ire-1.alpha. inhibitors
10/13/2011	CA2795289A1 Methods and compositions for enhanced delivery of compounds
10/13/2011	CA2795279A1 Antibodies to cd122
10/13/2011	CA2795085A1 Indolyl or indolinyl hydroxamate compounds
10/13/2011	CA2794801A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
10/13/2011	CA2794565A1 Substituted androst-4-ene diones
10/13/2011	CA2794112A1 Antimetastatic compounds
10/13/2011	CA2791324A1 Kinase inhibitors and method of treating cancer with same
10/13/2011	CA2789818A1 Inverse agonists and neutral antagonists for the tsh receptor
10/12/2011	EP2375251A1 Auxiliary method for diagnosis and therapy of cancer with nucleolin
10/12/2011	EP2374884A2 Human miRNAs isolated from mesenchymal stem cells
10/12/2011	EP2374883A1 Anti-cd4 antibody
10/12/2011	EP2374880A1 Method for inhibiting proliferation of cells
10/12/2011	EP2374876A2 Therapy for alpha-galactosidase a deficiency
10/12/2011	EP2374825A1 Photodynamic therapeutic agent showing accumulation of cell-specific functions
10/12/2011	EP2374814A2 Peptides that ellicit T cellular immunity
10/12/2011	EP2374807A2 An improved process for the isolation of temozolomide
10/12/2011	EP2374802A1 Kynurenine production inhibitor
10/12/2011	EP2374794A1 Cyclic amine compounds
10/12/2011	EP2374788A1 Indanyl compounds
10/12/2011	EP2374463A1 Composition for improving radiotherapy for cancer
10/12/2011	EP2374454A1 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/12/2011	EP2374453A1 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
10/12/2011	EP2373789A1 Membrane type-1 matrix metalloprotein inhibitors and uses thereof
10/12/2011	EP2373688A1 A monoclonal antibody and its use for the identification of the oncofetal isoform of fibronectin (b-fn) for diagnosis or therapy
10/12/2011	EP2373674A1 2-(n-substituted piperazinyl) steroid derivatives
10/12/2011	EP2373664A1 Bicyclic pyrazoles as protein kinase inhibitors
10/12/2011	EP2373663A1 Thienopyridines as pharmacologically active agents
10/12/2011	EP2373662A2 Thieno[3,2-c]pyridine derivatives as kinase inhibitors for use in the treatment of cancer
10/12/2011	EP2373658A2 Stat3 inhibitors and therapeutic methods using the same
10/12/2011	EP2373657A1 5, 7-dihydro- 6h-pyrimido ý 5, 4-d¨ý 1¨benzazepin-6-thiones as plk inhibitors
10/12/2011	EP2373656A1 Cinnamido-pvrrolor[2,1-c][1,4]benzodiazepines as potential anticancer agents and process for the preparation thereof
10/12/2011	EP2373647A1 Pyridazinone derivatives
10/12/2011	EP2373645A1 Isoindolinone and related analogs as sirtuin modulators
10/12/2011	EP2373644A1 Pyridazinone derivatives
10/12/2011	EP2373640A1 Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
10/12/2011	EP2373636A1 Inhibitors of phosphoinositide dependent kinase 1 (pdk1)
10/12/2011	EP2373635A1 Benzothiazolone derivative
10/12/2011	EP2373629A1 Compounds for treating cancer
10/12/2011	EP2373626A1 Substituted indazole derivatives active as kinase inhibitors
10/12/2011	EP2373624A1 Transition metal complexes of a bisýthiohydrazide amide¨compound
10/12/2011	EP2373618A2 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
10/12/2011	EP2373610A1 Plant extracts from acronychia species and their use
10/12/2011	EP2373382A1 Gnaq targeted dsrna compositions and methods for inhibiting expression
10/12/2011	EP2373343A1 Immunocytokines for tumour therapy with chemotherapeutic agents
10/12/2011	EP2373338A2 Annexina2 as immunological target
10/12/2011	EP2373337A1 Monoclonal antibodies directed against lg4-5 domain of alpha3 chain of human laminin-5
10/12/2011	EP2373320A1 Use of ammonium chloride in therapy
10/12/2011	EP2373318A1 Imidazopyrazine syk inhibitors
10/12/2011	EP2373313A1 Substituted pyrazole compounds
10/12/2011	EP2373309A1 Anticancer combination comprising docetaxel and an antisense oligonucleotide
10/12/2011	EP2373308A2 Combination therapy for the treatment of cancer
10/12/2011	EP2373305A1 Transdermal pharmaceutical compositions comprising a serm
10/12/2011	EP2373302A1 The use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them
10/12/2011	EP2252322B1 Vaccine compositions
10/12/2011	EP2168964B1 Azaindole-indole coupled derivatives, preparation methods and uses thereof
10/12/2011	EP2064189B1 Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one
10/12/2011	EP1919906B1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
10/12/2011	EP1778238B1 Dihydropteridinone infusion solution having a long shelf life
10/12/2011	EP1695955B1 Compounds having lysophosphatidic acid receptor antagonism and uses thereof
10/12/2011	EP1541584B1 A group of novel synthetic antibiotic peptides
10/12/2011	EP1538888B1 Upper hitch link
10/12/2011	EP1487482B1 Dna vaccine against proliferating endothelial cells and methods of use thereof
10/12/2011	EP1366022B1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN1934101B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof

1 ... 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 ... 2211